SHARE

AstraZeneca reports high-level results from late-stage trial of cancer drug

The Cambridge-based drug maker has seen positive results from its new cancer medicine which will be used to help manage and improve breast cancer. This is the first of seven new drugs in phase III development this year by AstraZeneca.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.